Lombard Odier Asset Management (Switzerland)’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,023
Closed -$2.49M 179
2023
Q1
$2.49M Sell
20,023
-23,535
-54% -$3.23M 0.22% 110
2022
Q4
$6.54M Sell
43,558
-22,616
-34% -$3.48M 0.52% 51
2022
Q3
$8.93M Sell
66,174
-74,784
-53% -$11.4M 0.76% 42
2022
Q2
$21M Buy
140,958
+21,647
+18% +$3.31M 1.78% 11
2022
Q1
$20.4M Buy
+119,311
New +$20M 1.6% 27
2021
Q4
Sell
-59,023
Closed -$16.1M 378
2021
Q3
$16.1M Sell
59,023
-34,816
-37% -$11.1M 1% 43
2021
Q2
$21M Buy
+93,839
New +$17.7M 1.07% 41

Other funds holding BNTX

Lombard Odier Asset Management (Switzerland)'s BNTX Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 20,023 shares — an estimated $2.49M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in BNTX in Q2 2021 and held it in 7 quarters. The position peaked at $21M in Q2 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 20,023 BioNTech shares in Q2 2023, an estimated $2.49M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in BioNTech in Q2 2021 and held it in 7 quarters.
  • Lombard Odier Asset Management (Switzerland)'s BioNTech position peaked at $21M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.